Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07630402 · ClinicalTrials.gov registry record · NA
Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
A NA study, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07630402 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 20 participants.
The verdict
NCT07630402, a NA study, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).
Interventions
- PROCEDURE Echocardiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2031-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07630402
The ClinicalTrials.gov registry entry for NCT07630402 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echocardiogram is the first listed.
NCT07630402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07630402 about?
NCT07630402 is a clinical study titled "Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer". The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).
What is the current status of trial NCT07630402?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-11-17. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07630402?
The interventions under investigation include: Echocardiogram (PROCEDURE).
Who is sponsoring clinical trial NCT07630402?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.